Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Evogene Ltd. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 27 | 28 | +1 |
| Shares | 797.9K | 711.0K | −86.9K (−10.9%) |
| Value | $500.6K | $759.5K | +$258.9K (+51.7%) |
New holders (6)
Institutions that held Evogene Ltd. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 100,000 | $107.0K | 0.04% |
| Jane Street Group, LLC | 27,466 | $29.4K | 0.00% |
| Virtu Financial LLC | 27,333 | $29.0K | 0.00% |
| Quent Capital, LLC | 12,000 | $12.8K | 0.00% |
| Two Sigma Securities, LLC | 10,958 | $11.7K | 0.00% |
| Coppell Advisory Solutions LLC | 27 | $30 | 0.00% |
Sold out (5)
Institutions that held Evogene Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 78,609 | $50.0K |
| Rockefeller Capital Management L.P. | 20,000 | $12.0K |
| Susquehanna International Group, LLP | 12,271 | $7.73K |
| Creative Capital Management Investments LLC | 200 | $126 |
| JPMorgan Chase & Co | 71 | $0 |